Leonhardt Ventures LLC and Licensee Lionheart Health, Inc. Granted U.S. Patent for Bioelectric Stem Cell Homing, Proliferation and Differentiation Control

by lionhearthealt | Dec 20, 2024 | News

Leonhardt Ventures LLC and Licensee Lionheart Health, Inc. Granted U.S. Patent for Bioelectric Stem Cell Homing, Proliferation and Differentiation Control Dec. 20th, 2024 – Irvine, California –(AINewsworthy)– Leonhardt Ventures LLC is pleased to...

Lionheart Health Presentation LSI Emerging Medtech Summit 2023

by lionhearthealt | Apr 18, 2023 | Uncategorized

Industry Veteran Brian Lasater joins Leonhardt Ventures LLC as Chief Technology Officer

by lionhearthealt | Mar 30, 2023 | Uncategorized

NEWS PROVIDED BY Leonhardt Ventures LLC 30th Mar, 2023, 9:00am PT Mission Viejo, CA , March 30th, 2023 /PRDistribution/ — Leonhardt Ventures LLC announces today that Brian Lasater has joined earlier this year the firm as Chief Technology Officer. In this role,...

Lionheart Health Biologics & Topicals

by lionhearthealt | Sep 15, 2022 | Biologics & Topicals

1. Adipose tissue processing a. SynovaLife Beside Adipose Tissue Processor – Click Hereb. Tissue Genesis Adipose Tissue Processor – Click Herec. Fisher Scientific StemPro Adipose Tissue Processing Kit – Click Here 2. Bio-PRF Bioelectric Platelet Rich...

Leonhardt Ventures Announces Filing of Pioneering Patent Application for Bioelectric Protein Expression Control of the SIRT

by lionhearthealt | Aug 25, 2022 | Uncategorized

SIRT signaling proteins (1-7) are involved in metabolic regulation, inflammation, neurodegeneration, cell cycle/tumorigenesis, Insulin secretion, DNA repair, and rDNA transcription and play a key role during cell response to a variety of stresses, such as oxidative or...